Journal of Cancer Research and Clinical Oncology

, Volume 142, Issue 7, pp 1499–1508 | Cite as

Exploring an herbal “wonder cure” for cancer: a multidisciplinary approach

  • Eran Ben-AryeEmail author
  • Jamal Mahajna
  • Radi Aly
  • Mohammed Saleem Ali-Shtayeh
  • Yedidia Bentur
  • Efraim Lev
  • Gary Deng
  • Noah Samuels
Original Article - Cancer Research


Context and objectives

The unmonitored use of herbal medicinal remedies by patients with cancer presents a significant challenge to oncology healthcare professionals. We describe an increasingly popular herbal “wonder drug,” Ephedra foeminea (Alanda in Arabic), whose use has spread from the Palestinian patient population throughout the Middle East. We conducted a multicentered and multidisciplinary collaborative research effort in order to understand the potential benefits and harms of this popular herbal remedy.


We conducted an in-depth search of the medical literature, both traditional and modern, for any mention of the clinical use of Alanda for the treatment of cancer. We then tested the remedy, first for toxic ephedra alkaloid components and then for anticancer effects, as well as effects on the cytotoxic activity of chemotherapy agents (cisplatin and carboplatin) on breast cancer cell cultures.


We found no mention in the literature, both conventional and traditional, on the use of Alanda for the treatment of cancer. Laboratory testing did not find any toxic components (i.e., ephedra alkaloids) in the preparation. However, in vitro exposure to Alanda led to a reduced cytotoxic effect of chemotherapy on breast cancer cell cultures.


The use of an integrative ethnobotanical, laboratory and clinical research-based approach can be extremely helpful when providing nonjudgmental and evidence-based guidance to patients with cancer, especially on the use of traditional herbal medicine. The effectiveness and safety of these products need to be examined by integrative physicians who are dually trained in both complementary medicine and supportive cancer care.


Integrative medicine Herbal medicine Complementary medicine Quality-of-life (QOL) Drug–herb interactions Ephedra foeminea 



We thank Abu-Sabri Saleh Said Khair, traditional herbal practitioner, Peqi'in, Israel; Ehud (Udi Wolf), PhD, the director of the Analytic Laboratory, Division of Identification & Forensic Sciences, Israel Police, Jerusalem, Israel; Michal Rotenberg, PhD, the head of the Clinical Toxicology and Pharmacology Laboratory, Sheba Medical Center, Tel Hashomer, Israel; Nihaya M.Y. Salameh, MSc, Researcher, Biodiversity & Environmental Research Center, BERC, Til, Nablus, Palestine; and Farah Raslan, MSc, Cancer Drug Discovery Program, Galilee Technology Center, Kiryat Shmona, Israel.

Authors’ contribution

All authors contributed equally to the design and drafting of the article.

Compliance with ethical standards

Conflict of interest

Prof. Eran Ben-Arye declares that he has no conflict of interest. Dr. Jamal Mahajna declares that he has no conflict of interest. Dr. Radi Aly declares that he has no conflict of interest. Dr. Mohammed Saleem Ali-Shtayeh declares that he has no conflict of interest. Prof. Yedidia Bentur declares that he has no conflict of interest. Prof. Efraim Lev declares that he has no conflict of interest. Dr. Gary Deng declares that he has no conflict of interest. Dr. Noah Samuels declares that he has no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. Ali-Shtayeh MS, Jamous RM, Jamous RM (2011) Herbal preparation use by patients suffering from cancer in Palestine. Complement Ther Clin Pract 17(4):235–240CrossRefPubMedGoogle Scholar
  2. Almog L, Lev E, Schiff E, Linn S, Ben-Arye E (2014) Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel. Support Care Cancer 22(10):2793–2804CrossRefPubMedGoogle Scholar
  3. Ben-Arye E, Schiff E, Shapira C, Frenkel M, Shalom T, Steiner M (2012) Modeling an integrative oncology program within a community-centered oncology service in Israel. Patient Educ Couns 89(3):423–429CrossRefPubMedGoogle Scholar
  4. Ben-Arye E, Massalha E, Bar-Sela G, Silbermann M, Agbarya A, Saad B, Lev E, Schiff E (2014a) Stepping from traditional to integrative medicine: perspectives of Israeli-Arab patients on complementary medicine’s role in cancer care. Ann Oncol 25(2):476–480CrossRefPubMedGoogle Scholar
  5. Ben-Arye E, Halabi I, Attias S, Goldstein L, Schiff E (2014b) Asking patients the right questions about herbal and dietary supplements: cross cultural perspectives. Complement Ther Med 22(2):304–310CrossRefPubMedGoogle Scholar
  6. Ben-Arye E, Hamadeh AM, Schiff E, Jamous RM, Dagash J, Jamous RM, Agbarya A, Bar-Sela G, Massalha E, Silbermann M, Ali-Shtayeh MS (2015) Compared perspectives of Arab patients in Palestine and Israel on the role of complementary medicine in cancer care. J Pain Symptom Manag 49(5):878–884CrossRefGoogle Scholar
  7. Ben-Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, Charalambous H, Dweikat T, Ghrayeb I, Bar-Sela G, Turker I, Hassan A, Hassan E, Saad B, Nimri O, Kebudi R, Silbermann M (2016a) Potential risks associated with traditional herbal medicine use in cancer care: a study of Middle Eastern oncology health care professionals. Cancer 122(4):598–610CrossRefPubMedGoogle Scholar
  8. Ben-Arye E, Popper-Giveon A, Samuels N, Mutafoglu K, Schiff E, Omran S, Charalambous H, Dweikat T, Ghrayeb I, Turker I, Hassan A, Hassan E, Nimri O, Kebudi R, Silbermann M (2016b) Communication and integration: a qualitative analysis of perspectives among Middle Eastern oncology healthcare professionals on the integration of complementary medicine in supportive cancer care. J Cancer Res Clin Oncol. 1 Feb 2016 [Epub ahead of print]Google Scholar
  9. Blaheta RA, Nelson K, Haferkamp A, Juengel E (2016) Amygdalin, quackery or cure? Phytomedicine 23(4):367–376CrossRefPubMedGoogle Scholar
  10. Bonakdar RA (2002) Herbal cancer cures on the Web: noncompliance with the Dietary Supplement Health and Education Act. Fam Med 34(7):522–527PubMedGoogle Scholar
  11. Cassileth BR, Yarett IR (2012) Cancer quackery: the persistent popularity of useless, irrational ‘alternative’ treatments. Oncology (Williston Park) 26(8):754–758Google Scholar
  12. Internet site: Accessed 6 April 2016
  13. Koehl B, Muenstedt K, Micke O, Muecke R, Buentzel J, Stoll C, Prott FJ, Dennert G, Senf B, Huebner J (2014) Survey of German non-medical practitioners regarding complementary and alternative medicine in oncology. Oncol Res Treat 37(1–2):49–53CrossRefPubMedGoogle Scholar
  14. Krizevski R, Bar E, Shalit O, Sitrit Y, Ben-Shabat S, Lewinsohn E (2010) Composition and stereochemistry of ephedrine alkaloids accumulation in Ephedra sinica Stapf. Phytochemistry 71(8–9):895–903CrossRefPubMedGoogle Scholar
  15. Lev E (2002) Medicinal substances of the medieval Levant. Eretz Publications, Tel AvivGoogle Scholar
  16. Lev E (2006) Ethno-diversity within current ethno-pharmacology as part of Israeli traditional medicine—a review. J Ethnobiol Ethnomed 2:4CrossRefPubMedPubMedCentralGoogle Scholar
  17. Lev E, Amar Z (2008) Practical materia medica of the medieval Eastern Mediterranean according to the Cairo Genizah. Brill, LeidenGoogle Scholar
  18. Metz J (2003) A multi-institutional study of Internet utilization by radiation oncology patients. Int J Radiat Oncol Biol Phys 56(4):1201–1205CrossRefPubMedGoogle Scholar
  19. Natural Medicines comprehensive database (2015) Internet site: Accessed 2 Oct 2015
  20. Philips J (1958) Some Lebanese materia medica. Ph.D. Thesis published in Lebanese Folk Cure. Columbia University, pp 120–121Google Scholar
  21. Sloan-Kettering Herb Reference (2015) Internet site: Accessed 16 Dec 2015
  22. Woolf AD, Watson WA, Smolinske S, Litovitz T (2005) The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993–2002. Clin Toxicol (Phila) 43(5):347–355CrossRefGoogle Scholar
  23. Yin A, Lawrence DF, Constantin FA (2013) Identifying unproven cancer treatments on the health web: addressing accuracy, generalizability and scalability. Stud Health Technol Inf 192:667–671Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Eran Ben-Arye
    • 1
    • 2
    • 3
    • 11
    Email author
  • Jamal Mahajna
    • 4
  • Radi Aly
    • 5
  • Mohammed Saleem Ali-Shtayeh
    • 6
  • Yedidia Bentur
    • 7
  • Efraim Lev
    • 8
  • Gary Deng
    • 9
  • Noah Samuels
    • 1
    • 2
    • 10
  1. 1.Integrative Oncology Program, Haifa and Western Galilee Oncology ServiceClalit Health ServicesHaifaIsrael
  2. 2.Lin Medical Center, Affiliated with the Rappaport Faculty of MedicineTechnion-Israel Institute of TechnologyHaifaIsrael
  3. 3.Complementary and Traditional Medicine Unit, Department of Family Medicine, Affiliated with the Rappaport Faculty of MedicineTechnion-Israel Institute of TechnologyHaifaIsrael
  4. 4.Cancer Drug Discovery ProgramGalilee Technology CenterKiryat ShmonaIsrael
  5. 5.Department of Plant Pathology and Weed Research, ARONewe-Yaar Research CenterRamat YishayIsrael
  6. 6.Biodiversity and Biotechnology Research UnitBiodiversity and Environmental Research Center, BERCTil, NablusPalestine
  7. 7.Israel Poison Information Center, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus, The Rappaport Faculty of MedicineTechnion-Israel Institute of TechnologyHaifaIsrael
  8. 8.Department of Eretz Israel StudiesUniversity of HaifaHaifaIsrael
  9. 9.Integrative Medicine ServiceMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  10. 10.Tal Center for Integrative Medicine, Institute of OncologySheba Medical CenterTel HashomerIsrael
  11. 11.The Oncology ServiceLin Medical CenterHaifaIsrael

Personalised recommendations